Condition: Dyslexia, Developmental · Developmental Language Disorder · Specific Learning Disorder · Sponsor: Helsinki University Central Hospital
The purpose of this study is to evaluate the effectiveness of BEATLE with clinical samples of patients diagnosed with Developmental Language Disorder (DLD), Dyslexia, and Mixed Specific Developmental Disorder. A randomized controlled trial with a waitlist design will be employed. The objective is to assess potential changes in perceived self-efficacy, self-compassion, executive functioning, and attitudes toward learning as reported by the participants, their guardians (parents), and teachers. Additionally, this study aims to examine the correlation between the usage of the Digital Care Pathway (DCP) and its effectiveness.
This description comes directly from the study's public registry record.
Markus S. Hannukkala, PhD Student, M.A. · +358407057351 · samuel.hannukkala@hus.fi
Always discuss trial participation with your own doctor first.
| Pediatric Neurology, Helsinki University Hospital | Helsinki, Finland | Recruiting |
| Phoniatrics, Helsinki University Hospital | Helsinki, Finland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06713863